Abstract
Formulations containing Ephedra sinica Stapf. (Ephedraceae) and Citrus aurantium L. (Rutaceae) are consumed worldwide for body weight control. Considering the related adverse effects and the risk potential, the aim of this study is to evaluate the effects of the thermogenic compounds ephedrine, p-sinephrine, E. sinica and C. aurantium in the female reproductive system through the uterotrophic assay in immature female rats. The animals (n = 6–7) received E. sinica 85.5 and 855.0 mg/kg/day, C. aurantium 25.0 and 50.0 mg/kg/day, ephedrine 5.0 mg/kg/day and p-synephrine 50.0 mg/kg/day for three consecutive days by oral gavage. For detection of antiestrogenicity, tamoxifen 20.0 mg/kg/day, E. sinica 855.0 mg/kg/day, C. aurantium 50.0 mg/kg/day, ephedrine 5.0 mg/kg/day and p-synephrine 50.0 mg/kg/day were administered to estrogen-treated females. Macroscopical alterations were evaluated in liver, kidneys, adrenals and uterus. All analyzed substances showed an antiestrogenic potential, but only ephedrine at 0.5 mg/kg/day presented a significative antiestrogenic effect (P < 0.01). Adrenals relative mass were reduced (P < 0.01) in all tested compounds when compared to the control, which seems to be related to the alfa-1-adrenoceptor agonist activity, which promote a vasoconstriction and reduction of the liquid in the organ. The endocrine system is highly complex and there are a number of ways in which a chemical may interfere with it, other in vivo and in vitro assays are being necessary to support this mechanism of action.
Similar content being viewed by others
References
AHFS - American Hospital Formulary Service Drug Information (2005) American Society of Health-System Pharmacists. Bethesda, USA
Andrade AJM, Araújo S, Santana GM, Ohi M, Dalsenter PR (2002) Screening for in vivo (anti)estrogenic and (anti)androgenic activities of technical and formulated delthamethrin. Regul Toxicol Pharmacol 35:379–382
Andraws R, Chawla P, Brown DL (2005) Cardiovascular effects of ephedra alkaloids: a comprehensive review. Prog Cardiovasc Dis 47:217–225
Baker VA (2001) Endocrine disrupters: testing strategies to assess human hazard. Toxicol In Vitro 15:413–419
Fugh-Bergman A, Myers A (2004) Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research. Exp Biol Med 299:698–704
Dalsenter PR, Cavalcanti AM, Andrade AJM, Araújo SL, Marques MCA (2004) Reproductive evaluation of aqueous crude extract of Achillea millefolium L. (Asteraceae) in Wistar rats. Reprod Toxicol 18:819–823
De Smet PAGM (2004) Health risks of herbal remedies: an update. Clin Pharmacol Ther 76:1–17
JPXIII (1996) The Japanese Pharmacopoeia. The Society of Japanese Pharmacopoeia, Tokyo
Odum J, Lefevre PA, Tittensor S, Paton D, Routledge EJ, Beresford NA, Sumpter JP, Ashby J (1997) The rodent uterotrophic assay: critical protocol features, studies with phenols, and comparison with a yeast estrogenicity assay. Regul Toxicol Pharmacol 25:176–188
Schaneberg BT, Crockett S, Bedir E, Khan IA (2003) The role of chemical fingerprinting: application to Ephedra. Phytochemistry 62:911–918
Acknowledgments
This work was supported by CNPQ (Processo 478054/2006-8) and FEPPS (animals donation).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arbo, M.D., Franco, M.T., Larentis, E.R. et al. Screening for in vivo (anti)estrogenic activity of ephedrine and p-synephrine and their natural sources Ephedra sinica Stapf. (Ephedraceae) and Citrus aurantium L. (Rutaceae) in rats. Arch Toxicol 83, 95–99 (2009). https://doi.org/10.1007/s00204-008-0324-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-008-0324-8